Article Versions Notes

Sun W, Wong ILK, Law HK-W, Su X, Chan TCF, Sun G, Yang X, Wang X, Chan TH, Wan S, et al. In Vivo Reversal of P-Glycoprotein-Mediated Drug Resistance in a Breast Cancer Xenograft and in Leukemia Models Using a Novel, Potent, and Nontoxic Epicatechin EC31. International Journal of Molecular Sciences. 2023; 24(5):4377. https://doi.org/10.3390/ijms24054377

Sun, Wenqin, Iris L. K. Wong, Helen Ka-Wai Law, Xiaochun Su, Terry C. F. Chan, Gege Sun, Xinqing Yang, Xingkai Wang, Tak Hang Chan, Shengbiao Wan, and et al. 2023. "In Vivo Reversal of P-Glycoprotein-Mediated Drug Resistance in a Breast Cancer Xenograft and in Leukemia Models Using a Novel, Potent, and Nontoxic Epicatechin EC31" International Journal of Molecular Sciences 24, no. 5: 4377. https://doi.org/10.3390/ijms24054377

Sun, W., Wong, I. L. K., Law, H. K. -W., Su, X., Chan, T. C. F., Sun, G., Yang, X., Wang, X., Chan, T. H., Wan, S., & Chow, L. M. C. (2023). In Vivo Reversal of P-Glycoprotein-Mediated Drug Resistance in a Breast Cancer Xenograft and in Leukemia Models Using a Novel, Potent, and Nontoxic Epicatechin EC31. International Journal of Molecular Sciences, 24(5), 4377. https://doi.org/10.3390/ijms24054377